Senseonics and Ascensia announce FDA approval for one-year CGM system
Medical technology companies Senseonics and Ascensia Diabetes Care have announced receipt of the US Food and Drug Administration (FDA) approval…
Medical technology companies Senseonics and Ascensia Diabetes Care have announced receipt of the US Food and Drug Administration (FDA) approval…
The US Food and Drug Administration (FDA) has tagged Abbott’s recent recall of its faulty FreeStyle Libre 3 sensors as…
DexCom has released its second quarter (Q2) financials reporting a 15% growth in revenue to $1bn, up from $871.3m in…
US-based Know Labs has reported positive data from a proof-of-concept trial evaluating its device that non-invasively identifies the level of…
Medical technology innovator Roche has announced that its AI-enabled continuous glucose monitoring (CGM) solution has received the Conformité Européene mark,…
Roche, a biotechnology company with a focus on diagnostics, has announced that its AI-enabled continuous glucose monitoring system has gained…
Tandem Diabetes Care has shared positive new data from a user satisfaction and wearability survey, finding that 86% of participants…
Insulet is looking to expand the use of its tubeless insulin pump, Omnipod 5 automated insulin delivery system (Omnipod 5),…
Finnish tech-maker GlucoModicum will be upping manufacturing efforts of its Talisman CGM device following strong clinical data. The device combines…
The French Government are to offer national reimbursement for Dexcom’s ONE continuous glucose monitor (CGM) to patients treating their type…